Additionally, we have identified and confirmed that CD44 and ZFP36 represent two promising biomarkers and have a positive correlation with macrophages, offering potential efficacy in the recognition and development of mRNA vaccines for individuals with DKD. Here, CD44 is linked to diabetic kidney disease.